We have located links that may give you full text access.
Minimally invasive tubular retractor-assisted biopsy and resection of subcortical intra-axial gliomas and other neoplasms.
Journal of Neurosurgical Sciences 2018 December
BACKGROUND: Deep-seated, subcortical tumors represent a surgical challenge. The traditional approach to these lesions involve large craniotomies, fixed retractor systems, and extensive white matter dissection, each with their own associated morbidity. We describe our experience with the use of tubular retractors for accessing these deep-seated lesions.
METHODS: Fifty consecutive patients operated on for an intra-axial brain tumor (both biopsies and resection) from January 2016 to December 2017 by a single surgeon using tubular retractors with exoscopic visualization were prospectively identified and included in this consecutive case series.
RESULTS: Thirty-five patients (70%) underwent surgical resection and 15 (30%) underwent excisional biopsy for tumors located a median (interquartile range [IQR]) distance of 5.4 (4.5-6.1) cm below the cortical surface within the thalamus and/or basal ganglia in 12 (24%), centrum semiovale in 17 (34%), cerebellar in 8 (16%), peri-Rolandic in 6 (12%), visual tracts in 5 (10%), and intraventricular in 2 (4%). The median IQR percent resection was 100 (95-100)% and all patients had diagnostic tissue. Pathology was high grade glioma in 30 (60%), metastatic in 14 (28%), and cavernoma in 2 (4%). The postoperative median IQR KPS was 80 (80-90), where 18 (36%) had improved, 29 (58%) stable, and 3 (6%) worsened KPS as compared to preoperatively.
CONCLUSIONS: The tubular retractor is a useful tool in the armamentarium of brain tumor surgery, and the exoscope provides an ergonomic means of visualizing the surgical field. It is meant to be used as a tool to access and resect deep-seated lesions while preserving and displacing superficial white matter tracts and cortical regions, provide a protected corridor to minimize inadvertent tissue injury during the resection, and circumferential tissue retraction to minimize risk of ischemia and damage to white matter tracts. As with any procedure, there is a learning curve with this surgical adjunct.
METHODS: Fifty consecutive patients operated on for an intra-axial brain tumor (both biopsies and resection) from January 2016 to December 2017 by a single surgeon using tubular retractors with exoscopic visualization were prospectively identified and included in this consecutive case series.
RESULTS: Thirty-five patients (70%) underwent surgical resection and 15 (30%) underwent excisional biopsy for tumors located a median (interquartile range [IQR]) distance of 5.4 (4.5-6.1) cm below the cortical surface within the thalamus and/or basal ganglia in 12 (24%), centrum semiovale in 17 (34%), cerebellar in 8 (16%), peri-Rolandic in 6 (12%), visual tracts in 5 (10%), and intraventricular in 2 (4%). The median IQR percent resection was 100 (95-100)% and all patients had diagnostic tissue. Pathology was high grade glioma in 30 (60%), metastatic in 14 (28%), and cavernoma in 2 (4%). The postoperative median IQR KPS was 80 (80-90), where 18 (36%) had improved, 29 (58%) stable, and 3 (6%) worsened KPS as compared to preoperatively.
CONCLUSIONS: The tubular retractor is a useful tool in the armamentarium of brain tumor surgery, and the exoscope provides an ergonomic means of visualizing the surgical field. It is meant to be used as a tool to access and resect deep-seated lesions while preserving and displacing superficial white matter tracts and cortical regions, provide a protected corridor to minimize inadvertent tissue injury during the resection, and circumferential tissue retraction to minimize risk of ischemia and damage to white matter tracts. As with any procedure, there is a learning curve with this surgical adjunct.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app